Department of Pain Management, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.
Department of Pain Management, The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Neurol Res. 2021 Dec;43(12):1005-1012. doi: 10.1080/01616412.2021.1948765. Epub 2021 Jul 7.
To investigate whether small conductance Ca activated channels; Trigeminal ganglion; Trigeminal neuralgia. (SK3) exists in normal rats' trigeminal ganglions (TG) and its effect on their pain thresholds. In total, 110 healthy adult male Sprague-Dawley (SD) rats were involved in this study. Ten rats were dissected to collect their liver tissues, TG and DRG. The rest of the rats were randomly assigned to either the experimental group or the control group. The animal model of trigeminal neuralgia (TN) was established by infraorbital nerve ligation. The expression of SK3 channels in their livers, TG and dorsal root ganglions (DRG) were detected. And different doses of SK3 channel activator and inhibitor were administered to the rats in both groups 15 days after the operation; meanwhile, their pain thresholds were also measured. The expression of SK3 channel was found in TG. In the experimental group, the pain threshold was significantly decreased and there was a decreased level of SK3 than that in the control group at 15 days after operation. The administration of SK3 channel agonist (CyPPA) could significantly improve the pain threshold, while, the pain threshold decreased after administration of SK3 channel antagonist (Apamin). The SK3 channel may play a pivotal role in the pathogenesis of trigeminal neuralgia, and it may be one of the potential targets for the treatment of trigeminal neuralgia.
研究小电导钙激活钾通道(SK3)是否存在于正常大鼠三叉神经节(TG)中,及其对疼痛阈值的影响。
共纳入 110 只健康成年雄性 Sprague-Dawley(SD)大鼠。10 只大鼠用于解剖以收集其肝脏组织、TG 和背根神经节(DRG)。其余大鼠随机分为实验组和对照组。通过眶下神经结扎建立三叉神经痛(TN)动物模型。检测 SK3 通道在大鼠肝脏、TG 和 DRG 中的表达。术后 15 天,两组大鼠分别给予不同剂量的 SK3 通道激活剂和抑制剂,并测量其疼痛阈值。
在 TG 中发现了 SK3 通道的表达。实验组大鼠术后 15 天,疼痛阈值明显降低,SK3 水平低于对照组。给予 SK3 通道激动剂(CyPPA)可显著提高疼痛阈值,而给予 SK3 通道拮抗剂(Apamin)后疼痛阈值降低。
SK3 通道可能在三叉神经痛的发病机制中起关键作用,可能成为治疗三叉神经痛的潜在靶点之一。